Evaluation of mutagenicity of the antitubercular naphthylglycine hydrazides insalmonella typhimurium

N-(2-naphthyl)glycine hydrazide and N-methyl-N-(2-naphthyl) glycine hydrazide, which inhibitMycobacterium tuberculosis H₃₇ R_V and show activity against experimental tuberculosis, were evaluated for their mutagenic potential inSalmonella typhimurium. Both the compounds at concentration ranges from 0.1 Μgplate to 1000 Μg/plate failed to induce mutations at the histidine locus either directly or after treatment with rat liver homogenate fraction-“S-9”. N-(2-naphthyl)glycine hydrazide and its N-methyl derivative elicited toxicity at concentrations of 500 Μg/plate and 1000 Μg/plate. However, in the presence of the liver homogenate system, reduction in toxicity was noticed probably due to detoxification and/ or conjugation of the compounds. Under the assay conditions employed, standard mutagens like 4-nitroquinoline-N-oxide, 9-aminoacridine and benzo(a)pyrene were positive. The non-mutagenic nature of N-(2-naphthyl)glycine hydrazide and N-methyl-N-(2-naphthyl)glycine hydrazide should enhance their potential for inclusion in treatment protocols for management of tuberculosis